Iovance Biotherapeutics Inc (IOVA)
11.89
-0.47
(-3.80%)
USD |
NASDAQ |
Apr 15, 16:00
11.77
-0.12
(-1.01%)
After-Hours: 06:26
Iovance Biotherapeutics Enterprise Value: 3.042B for April 15, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 15, 2024 | 3.042B |
| April 12, 2024 | 3.173B |
| April 11, 2024 | 3.405B |
| April 10, 2024 | 3.235B |
| April 09, 2024 | 3.414B |
| April 08, 2024 | 3.372B |
| April 05, 2024 | 3.500B |
| April 04, 2024 | 3.520B |
| April 03, 2024 | 3.634B |
| April 02, 2024 | 3.567B |
| April 01, 2024 | 3.685B |
| March 28, 2024 | 3.860B |
| March 27, 2024 | 3.659B |
| March 26, 2024 | 3.645B |
| March 25, 2024 | 3.779B |
| March 22, 2024 | 3.916B |
| March 21, 2024 | 4.011B |
| March 20, 2024 | 3.891B |
| March 19, 2024 | 3.604B |
| March 18, 2024 | 3.640B |
| March 15, 2024 | 3.606B |
| March 14, 2024 | 3.690B |
| March 13, 2024 | 3.835B |
| March 12, 2024 | 3.833B |
| March 11, 2024 | 3.939B |
| Date | Value |
|---|---|
| March 08, 2024 | 4.106B |
| March 07, 2024 | 4.363B |
| March 06, 2024 | 4.514B |
| March 05, 2024 | 4.327B |
| March 04, 2024 | 4.458B |
| March 01, 2024 | 4.411B |
| February 29, 2024 | 4.165B |
| February 28, 2024 | 4.589B |
| February 27, 2024 | 4.601B |
| February 26, 2024 | 4.358B |
| February 23, 2024 | 4.126B |
| February 22, 2024 | 4.173B |
| February 21, 2024 | 3.760B |
| February 20, 2024 | 2.802B |
| February 16, 2024 | 2.065B |
| February 15, 2024 | 2.249B |
| February 14, 2024 | 2.167B |
| February 13, 2024 | 2.067B |
| February 12, 2024 | 2.270B |
| February 09, 2024 | 2.072B |
| February 08, 2024 | 1.944B |
| February 07, 2024 | 1.788B |
| February 06, 2024 | 1.811B |
| February 05, 2024 | 1.750B |
| February 02, 2024 | 1.745B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
483.88M
Minimum
Oct 19 2023
7.095B
Maximum
Feb 08 2021
2.512B
Average
2.223B
Median
Enterprise Value Benchmarks
| QuidelOrtho Corp | 5.018B |
| Perspective Therapeutics Inc | 890.47M |
| Electromed Inc | 115.63M |
| Xtant Medical Holdings Inc | 128.06M |
| Asensus Surgical Inc | 53.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -116.38M |
| Revenue (Quarterly) | 0.482M |
| Total Expenses (Quarterly) | 121.74M |
| EPS Diluted (Quarterly) | -0.45 |
| Gross Profit Margin (Quarterly) | -805.6% |
| Profit Margin (Quarterly) | -24.15K% |
| Earnings Yield | -15.81% |